Podcast Episodes
Back to SearchPropagating Peptides With Peptilogics' Jonathan Steckbeck, Ph.D.
We love to hear from our listeners. Send us a message.
The Business of Biotech took a road trip to Pittsburgh to visit with Peptilogics CEO and found…
2 years, 7 months ago
Resilient Biopharma Leadership With Ambrx's Dan O'Connor
We love to hear from our listeners. Send us a message.
Since Dan O'Connor stepped in as CEO at Ambrx late last year, the company's stock has rallied …
2 years, 7 months ago
Funding A Neurodegeneration Startup With Coya Therapeutics' Howard Berman
We love to hear from our listeners. Send us a message.
Like many of us, Howard Berman, Ph.D. has personal experience with the tragedy of cognitive de…
2 years, 8 months ago
A More NIIMBL Biotech Workforce With John Balchunas
We love to hear from our listeners. Send us a message.
What are biopharma's greatest skilled manufacturing labor needs, and what's the industry doing…
2 years, 8 months ago
Building Flagship Pioneering With Avak Kahvejian, Ph.D.
We love to hear from our listeners. Send us a message.
Flagship Pioneering is fertile ground for a bevy of blossoming biotechs, and one of its most p…
2 years, 8 months ago
Therapeutic Molecules From Moss with eleva's Andreas Schaaf and Björn Cochlovius, Ph.D.
We love to hear from our listeners. Send us a message.
We kick this conversation off with the writer Elizabeth Gilbert's take on moss, which she so e…
2 years, 8 months ago
Gene Tx For Hearing Loss with Sensorion's Nawal Ouzren
We love to hear from our listeners. Send us a message.
We often talk about biotechs taking "big swings." This week's guest is swinging for the fences…
2 years, 9 months ago
Functional Ectopic Organs with LyGenesis' Michael Hufford, Ph.D.
We love to hear from our listeners. Send us a message.
LyGenesis is developing a pipeline of allogeneic cell therapies using the lymph node as an in…
2 years, 9 months ago
Approvals & Mergers: Inside Enzyvant with Bill Symonds, Pharm.D.
We love to hear from our listeners. Send us a message.
Today's episode of the Business of Biotech covers a lot of ground with Enzyvant CEO Bill Symon…
2 years, 9 months ago
Next-Gen Nanobodies With MoonLake's Jorge Santos Da Silva, Ph.D.
We love to hear from our listeners. Send us a message.
The more we learn about inflammation and the complex cause/contributor/symptom roles it plays …
2 years, 9 months ago